期刊论文

Li, Wen;Da, Fu;Ma, Yu-Shui

英文

Molecular Therapy - Nucleic Acids

2162-2531

2021

23

702-718

10.1016/j.omtn.2020.12.016

This study was supported partly by grants from the National Key R&D Program of China ( 2018YFE0110200 ); the National Natural Science Foundation of China ( 81972214 , 81772932 , 81472202 , and 81302065 ); the Shanghai Natural Science Foundation ( 20ZR1472400 ); the Natural Science Foundation of Hunan Province of China ( 2020WK2020 , 2018JJ4061 , 2020JJ4278 , and 2020JJ5127 ); the Key Program of Hunan Provincial Department of Science and Technology ( 2019NK2111 ); the Scientific Research Fund of Hunan Provincial Education Department ( 18B290 ); the Zhuzhou Key Science & Technology Program of Hunan Province ( 2017 and 2019 ); the Construction of Clinical Medical Centre for Tumor Biological Samples in Nantong ( HS2016004 ), and by the Jiangsu 333 Program ( BRA2017205 ). This study was supported partly by grants from the National Key R&D Program of China (2018YFE0110200); the National Natural Science Foundation of China (81972214, 81772932, 81472202, and 81302065); the Shanghai Natural Science Foundation (20ZR1472400); the Natural Science Foundation of Hunan Province of China (2020WK2020, 2018JJ4061, 2020JJ4278, and 2020JJ5127); the Key Program of Hunan Provincial Department of Science and Technology (2019NK2111); the Scientific Research Fund of Hunan Provincial Education Department (18B290); the Zhuzhou Key Science & Technology Program of Hunan Province (2017 and 2019); the Construction of Clinical Medical Centre for Tumor Biological Samples in Nantong (HS2016004), and by the Jiangsu 333 Program (BRA2017205). Y.-S.M. D.F. and W.L. designed the study; Y.S. D.-D.Z. J.-B.L. X.-L.Y. R.X. C.-Y.J. H.-M.W. G.-X.L. P.-Y.W. Z.-J.L. Y.-S.M. D.F. and W.L. conducted the study; Y.S. D.-D.Z. Y.L. Z.-J.L. J.D. Q.-L.L. L.M. S.-S.F. X.-Q.C. X.-M.Z. Y.-F.Z. Y.-J.H. H.-Q.Y. L.-L.T. L.-P.G. Z.-W.L. F.Y. Y.-S.M. and D.F. collected data; Y.S, D.-D.Z. Y.-S.M. D.F. and W.L. performed the statistical analyses and interpreted the data; Y.-S.M. D.F. and W.L. contributed to study materials and consumables; and Y.S, Y.-S.M. D.F. and W.L. wrote the manuscript. All authors contributed to the final version of the manuscript and approved the final manuscript. The authors declare no competing interests.

本校为第一且通讯机构

Shi et al. provide evidence that a ceRNA-based DLEU2L/TAOK1 axis has an impact on changes in the tumor immune microenvironment and might be a novel important prognostic factor associated with the diagnosis and prognosis of HCC. © 2020 The Author(s)Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors that are harmful to human health. Increasing evidence has underscored the critical role of the competitive endogenous RNA (ceRNA) regulatory networks among various human cancers. However, the complexity and behavior characteristi...